Activity enhances dopaminergic long-duration response in Parkinson disease
Un Jung Kang(AOL (United States)), Stewart A. Factor(Parkinson's and Movement Disorder Institute), Anthony E. Lang(University of Toronto), Carol Moskowitz(Columbia University Irving Medical Center), Serge Gauthier(Texas Instruments (France)), John P. Hammerstad(Oregon Health & Science University), Stanley Fahn(Columbia University Irving Medical Center), Johan Samanta(Barrow Neurological Institute), Christopher G. Goetz(Rush University Medical Center), Mayank Pathak(Parkinson's and Movement Disorder Institute), Giovanni Schifitto(University of Rochester Medical Center), Joseph H. Friedman(University of Washington), David Oakes(University of Rochester), Alice Rudolph, Ira Shoulson(Baylor College of Medicine), John Seibyl(Elucid Bioimaging), Barbara Alexander-Brown(Oregon Health & Science University), Michael A. Schwarzschild(Massachusetts General Hospital), Danna Jennings, B. Fussell(Institute for Neurodegenerative Disorders), Caroline M. Tanner(NewYork–Presbyterian Hospital), Margaret C. Lannon(Brown University), Peggy Auinger(University of Rochester Medical Center), Mary Harrigan(Barrow Neurological Institute), Marsha Tennis, Daniel Truong(University of California, Los Angeles), Michel Panisset(Centre Hospitalier de l’Université de Montréal), Christine Hunter(Baylor College of Medicine), Farah Atassi(Baylor College of Medicine), Aileen Shinaman(University of Rochester), William G. Ondo(Houston Methodist), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Kenneth Marek(University of Pennsylvania), Hongwei Zhao(Shanxi Provincial Cancer Hospital), Blair Ford(Columbia University), Kelli Williamson(Barrow Neurological Institute), Lucia M. Blasucci(Rush University Medical Center), Karl Kieburtz(Rochester Institute of Technology), Stephen T. Gancher(Oregon Health & Science University), Mark Stacy(Duke University), Lydia Reyes(Columbia University), Joseph Jankovic(Baylor College of Medicine), Claudia Stone(Oregon Health & Science University), Carol Jacques(Brown University), Jean Hall, Paul Greene(Columbia University Irving Medical Center), John H. Growdon(Harvard University), David Russell(Yale University), Cynthia L. Comella(Rush University), David G. Standaert(University of Alabama at Birmingham)
Cited by 28
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
|Neurology|1992|2.7k
A polymorphic DNA marker genetically linked to Huntington's disease
|Nature|1983|2.3k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k